Wells Fargo: Analysts' Upgrades, Downgrades

NEW YORK (TheStreet) -- CHANGE IN RATINGS

ATMI

(ATMI)

upgraded at Citi to Hold from Sell. Wafer starts still about to roll. Price target trimmed to $15 from $18.

Ball Corp.

(BLL) - Get Report

upgraded at Goldman to Buy. Company should outperform in a slower growth environment.

Crown Holdings

(CCK) - Get Report

upgraded at Goldman to Buy. Company will likely aggressively buy back its stock.

Cerner

(CERN) - Get Report

upgraded at Jefferies from Hold to Buy. $87 price target. Stock has pulled back since April and the purchasing environment in improving.

Concur Technologies

(CNQR)

upgraded at Jefferies from Hold to Buy. $55 price target. Corporate travel activity has improved in the past few months.

Complete Production Services

( CPX) upgraded at Credit Suisse to Outperform from Neutral on increased earnings outlook, impressive margin growth. Price target jumped to $25 from $19.

Cognizant Technology Solutions

(CTSH) - Get Report

reinstated at BofA/Merrill with a Neutral rating and 458 price target. Growth potential not mispriced.

Eaton

(ETN) - Get Report

upgraded at Wells to Outperform. Estimates also boosted, as the company continues to grow in a slow environment.

Eaton

(ETN) - Get Report

estimates, target increased at Morgan Stanley. ETN estimates were raised through 2011. Company is seeing better demand across the board, outside of aerospace. Equal-weight rating and new $83 price target.

Human Genome

( HGSI) upgraded at Baird from Neutral to Outperform. $32 price target. Stock is down more than 20% this year, even though Benlysta will likely be approved by the FDA later this year.

Petrohawk Energy

(HK)

rated new Perform at Oppenheimer. Valuation call, given weak natural gas prices.

Owens-Illinois

(OI) - Get Report

downgraded at Goldman to Neutral. Estimates also cut, because of lower glass volume.

Pactiv

( PTV) downgraded at Goldman to Neutral. Valuation call.

SEI Investments

(SEIC) - Get Report

downgraded at KBW to Market Perform. Management has limited visibility on future growth.

Solarwinds

(SWI) - Get Report

downgraded at Jefferies from Buy to Hold. $14 price target. License weakness could continue and the network management market is mature.

STOCK COMMENTS / EPS CHANGES

Abbott Laboratories

(ABT) - Get Report

estimates upped at Morgan Stanley through 2011. Margins should continue to expand over the coming quarters. Overweight rating and $63 price target.

Alliance Data

(ADS) - Get Report

estimates lowered at Goldman through 2012, given the company's new guidance. Neutral rating and $63 price target.

AMR

(AMR)

estimates, target lowered at UBS. Shares of AMR now seen reaching $14. Estimates also cut, given the company's new guidance. Buy rating.

Autozone

(AZO) - Get Report

target upped at Goldman to $211. Industry has pricing power and should benefit from an aging car fleet. Neutral rating.

Baidu.com

(BIDU) - Get Report

estimates, target boosted at Goldman. Shares of BIDU now seen reaching $90. Estimates also upped, given a higher customer count. Buy rating.

CA Inc

(CA) - Get Report

price target cut at Credit Suisse to $20 from $22. Large bookings miss in 1Q results. Maintain Neutral rating.

Cephalon

( CEPH) estimates, target raised at Goldman. Shares of CEPH now seen reaching $68. Estimates also increased, to match the company's new guidance. Neutral rating.

CF industries

(CF) - Get Report

price target higher at BofA/Merrill. CF price target raised to $94 from $85. Expecting positive 2Q10 results. Maintain Buy rating.

Comerica

(CMA) - Get Report

estimates, target upped at UBS. Shares of CMA now seen reaching $28. Estimates also boosted, given the company's improved credit outlook. Sell rating.

EMC

(EMC)

price target higher at Citi. EMC price target raised by a dollar to $25. Selloff on modest 2010 beat represents buying opportunity. Maintain Buy rating.

Edwards Lifesciences

(EW) - Get Report

estimates upped at Morgan Stanley through 2012. Company should have a positive launch for Sapien. Equal-weight rating.

F5 Networks

(FFIV) - Get Report

price target boosted at Citi to $83 from $78. Another substantial beat and raise 2Q. Maintain Hold rating.

F5 Networks

(FFIV) - Get Report

estimates, target raised at UBS. Shares of FFIV now seen reaching $83. Estimates also increased, as the company is posting solid growth and seeing record margins. Neutral rating.

Greenhill

(GHL) - Get Report

estimates, target cut at Goldman. GHL estimates were reduced through 2012. Company is seeing lower advisory fees. Neutral rating and new $65 price target.

Coca-Cola

(KO) - Get Report

price target higher at BofA/Merrill. KO price target raised by a dollar to $63. 2Q volumes (+5%), margins (+210bps) better than forecasted. Maintain Buy rating.

Linear Technology

(LLTC)

estimates increased at UBS through 2012. Company continues to perform well, despite a murky macro outlook. Neutral rating and new $31 price target.

Manpower

(MAN) - Get Report

target, estimates boosted at Barclays. MAN price target raised by a dollar to $62. Robust 2Q performance and strong 3Q guidance. 2010 and 2011 EPS estimates lifted to $1.35 and $2.58, respectively. Maintain Overweight rating.

MKS Instruments

(MKSI) - Get Report

estimates increased at Goldman through 2012. Company is realizing better operating leverage. Neutral rating and $23 price target.

Altria

(MO) - Get Report

estimates boosted at BofA/Merrill. 2010, 2011, 2012 EPS estimates increased to $1.90, $2.03, $2.16, respectively. 2Q results showed tobacco momentum and execution. Maintain Buy and $24 price target.

Altria

(MO) - Get Report

estimates, target raised at Morgan Stanley. Shares of MO now seen reaching $22. Estimates also increased, given the better pricing and volume outlook. Equal-weight rating.

Morgan Stanley

(MS) - Get Report

numbers changed at Barclays. MS 2010 EPS estimates raised to $2.97, 2011 cut to $3.15. MS benefitted from agency business model. Maintain $34 price target and Equal Weight rating.

M&T Bank

(MTB) - Get Report

estimates, target boosted at UBS. Shares of MTB now seen reaching $89. Estimates also upped, given the company's improved credit quality. Neutral rating.

Netflix

(NFLX) - Get Report

target, estimates boosted at Credit Suisse. NFLX price target surged to $90 from $31 after 2Q10 revenue and EPS beat. 2010 and 2011 EPS estimates jumped to $2.82 and $3.69, respectively. Maintain Underperform rating.

Netflix

(NFLX) - Get Report

estimates, target raised at Oppenheimer. Shares of NFLX now seen reaching $110. Estimates also increased, given increased streaming usage and international expansion. Underperform rating.

Qualcomm

(QCOM) - Get Report

estimates, target raised at Goldman. Shares of QCOM now seen reaching $44. Estimates also increased, given continued smartphone growth. Buy rating.

Qualcomm

(QCOM) - Get Report

estimates, target lowered at UBS. Shares of QCOM now seen reaching $45. Estimates also cut, given the company's lower margins. Buy rating.

Qualcomm

(QCOM) - Get Report

estimates raised at Credit Suisse. QCOM 2010, 2011, 2012 EPS estimates increased to $2.33, $2.39, $2.50, respectively. Mixed 3Q results but CDMA/WCDMA market still seeing robust growth. Neutral rating and $40 price target.

Robert Half

(RHI) - Get Report

target, estimates higher at BofA/Merrill. RHI price target lifted to $25 from $23 on strong 2Q10 results. 2010 and 2011 EPs estimates raised to 40 cents and 86 cents, respectively. Underperform rating.

RLI

(RLI) - Get Report

estimates increased at Oppenheimer through 2011. Company has strong earnings momentum. Perform rating.

Starbucks

(SBUX) - Get Report

price target trimmed at Barclays to $26 from $28 on lower than expected 2011 estimates. 2010 and 2011 EPS estimate dropped to $1.23 and $1.40, respectively. Reiterate Equal Weight rating.

Textron

(TXT) - Get Report

estimates, target upped at Goldman. TXT estimates were boosted through 2012. Company is seeing solid growth, outside of Cessna. Buy rating and new $25 price target.

US Bancorp

(USB) - Get Report

estimates, target reduced at Morgan Stanley. Shares of USB now seen reaching $29. Estimates also cut, given higher legislative costs. Equal-weight rating.

Western Digital

(WDC) - Get Report

numbers lowered at UBS. WDC estimates were cut through 2012. Company is seeing margin contraction, though further downside could be limited. Buy rating and new $34 price target.

Wells Fargo

(WFC) - Get Report

2010 estimate raised at Barclays to $2.20 on strong 2Q10 performance. 2011 EPS estimate set at $3.00. Maintain Overweight rating and $36 price target.

Xilinx

(XLNX) - Get Report

estimates, target boosted at UBS. Shares of XLNX now seen reaching $35. Estimates also upped, given the company's secular growth trends. Buy rating.

This article was written by a staff member of TheStreet.